J&J reports higher earnings, despite lower sales

Date: Tuesday, October 13, 2009

J&J reports higher earnings, despite lower sales

Johnson & Johnson reports moderately higher third-quarter earnings,
but its sales performance was tempered by declining sales of two of
its top-selling prescription drugs, Topamax and Risperdal, due to
increased generic competition.

CISCO TO BUY STARENT FOR $2.9 BILLION

Cisco Systems on Tuesday said it has signed a $2.9 billion deal to buy
Starent Networks, its second major purchase in three weeks,
highlighting what appears to be the tech behemoth's aggressive buying
spree.

FOR POLYCOM, CISCO-TANDBERG DEAL IS MIXED BLESSING

Polycom Inc. has seen its stock soar this year on strong expectations
for the company's video-conferencing business, but Cisco Systems' plan
to buy a top rival may threaten its long-term outlook.

SUPREME COURT TO HEAR SKILLING'S APPEAL

The disgraced Enron chief has been allowed a hearing before the
Supreme Court after battling through the appeals process in the face
of a 24-year sentence.

CRUDE RISES AS OPEC RAISES DEMAND FORECAST

Crude futures rise above $74 a barrel, hitting the highest level in
seven weeks after the OPEC oil cartel revised higher its forecast for
global oil demand for this year and 2010.